Distribution of intravenously administered ferrioxamine-59 and ferric N,N'-ethylenebis (alpha imino-2-hydroxy-5-chlorophenylacetate) in rats.
D000818:Animals; D001609:Beta-Globulins; D055598:Chemical Phenomena; D002621:Chemistry; D003676:Deferoxamine; D007413:Intestinal Mucosa / Q000378:metabolism; D007502:Iron Chelating Agents / Q000097:blood / Q000378:metabolism*; D007503:Iron Isotopes; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D010648:Phenylacetates / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D013154:Spleen / Q000378:metabolism; D001743:Urinary Bladder / Q000378:metabolism
D001609:Beta-Globulins; D007502:Iron Chelating Agents; D007503:Iron Isotopes; D010648:Phenylacetates; D003676:Deferoxamine